Strengthening tuberculosis (TB) prevention, diagnosis, treatment, and surveillance in Asia

The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $3,000,000 for Year 1, subject to the availability of funds. The purpose of this NOFO is to reduce TB-related morbidity and mortality in India, the Philippines, and Vietnam by strengthening: • TB case finding, including linked activities such as screening, testing, and diagnostic evaluation. • TB prevention, including TB preventive treatment (TPT). • TB treatment, including linkage and improved treatment regimens, as appropriate. • Surveillance, through adopting, evaluating, and expanding innovative approaches. Activities implemented will focus on: • Expanding and improving diagnosis of TB infection and TB disease, including early and asymptomatic TB as well as drug-resistant or multidrug-resistant TB. This will be done by using and evaluating innovative screening and diagnostic methods and scaling up evidence-based approaches. • Improving TPT outcomes for all individuals at high risk of developing TB disease and improving TB treatment outcomes of individuals with TB disease, including those with drug-resistant or multidrug-resistant TB. This will be done by using new, shorter, and better-tolerated treatment regimens. • Strengthening TB surveillance for data-driven decision making, program planning, and public health action. Asia carries the highest burden of TB and drug-resistant or multidrug-resistant TB globally. This NOFO will focus on activities in India, the Philippines, and Vietnam because they are three of the top four countries contributing to the TB burden in the U.S. This aligns with the America First Global Health Strategy.